Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RegenOSF: Alternating TA and PRP for Oral Submucous Fibrosis
NCT07277998Not yet recruiting
- Sponsor
- Karachi Medical and Dental College
- Start
- Mar 2026
- Primary completion
- Jul 2026
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Trial of platelet-rich plasma in Oral submucous fibrosis (OSF) (2 arms), sponsored by Karachi Medical and Dental College. Primary endpoints: Change in Interincisal Distance at Week 12 and Change in Burning Sensation at Week 12. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
Oral submucous fibrosis (OSF)
Beyond the preview
Go deeper on NCT07277998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07277998.